The Potential Impact of Coronavirus (COVID-19) on US Pharma and Biotech Companies
April 2, 2020

Pharmaceutical and biotech companies in the US and around the globe are working with governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges.

Healthcare systems are being put under significant pressure, at a time when many are already over-stretched, medical congresses are being cancelled, and bans on non-essential travel and enforced home-working are emerging. 

At IQVIA, we are mobilizing our capabilities and resources to help governments, patients, healthcare providers, life sciences, and others understand what's happening and how we can reduce the impact of this virus, together.

As part of this effort, we have developed this webinar with expert speakers from IQVIA who will outline potential scenarios, considerations, and decisions that pharma and biotech should plan for.